Anaplan Inc (PLAN)

US03272L1089 - Common Stock

63.73  +0.37 (+0.58%)

After market: 63.74 +0.01 (+0.02%)

Fundamental Rating

3

PLAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 275 industry peers in the Software industry. PLAN has a bad profitability rating. Also its financial health evaluation is rather negative. PLAN is valued quite expensive, but it does show an excellent growth.



0

1. Profitability

1.1 Basic Checks

In the past year PLAN has reported negative net income.
In the past 5 years PLAN always reported negative net income.
PLAN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -27.06%
ROE N/A
ROIC -60.67%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -35.42%
PM (TTM) -33.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

PLAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PLAN has more shares outstanding than it did 1 year ago.
PLAN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PLAN has been reduced compared to a year ago.

2.2 Solvency

PLAN has an Altman-Z score of 9.19. This indicates that PLAN is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.03 indicates that PLAN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 9.19
ROIC/WACC-8.59
WACC7.06%

2.3 Liquidity

PLAN has a Current Ratio of 1.08. This is a normal value and indicates that PLAN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.08 indicates that PLAN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08

7

3. Growth

3.1 Past

PLAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.85%.
Looking at the last year, PLAN shows a very strong growth in Revenue. The Revenue has grown by 33.31%.
The Revenue has been growing by 37.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q80%
Revenue 1Y (TTM)33.31%
Revenue growth 3Y35.02%
Revenue growth 5Y37.5%
Revenue growth Q2Q30.3%

3.2 Future

Based on estimates for the next years, PLAN will show a very strong growth in Earnings Per Share. The EPS will grow by 63.38% on average per year.
The Revenue is expected to grow by 24.18% on average over the next years. This is a very strong growth
EPS Next Y44.31%
EPS Next 2Y38.74%
EPS Next 3Y52.89%
EPS Next 5Y63.38%
Revenue Next Year27.86%
Revenue Next 2Y25.85%
Revenue Next 3Y25.19%
Revenue Next 5Y24.18%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

PLAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PLAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -47.72

4.3 Compensation for Growth

A more expensive valuation may be justified as PLAN's earnings are expected to grow with 52.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.74%
EPS Next 3Y52.89%

0

5. Dividend

5.1 Amount

No dividends for PLAN!.
Industry RankSector Rank
Dividend Yield N/A

Anaplan Inc

NYSE:PLAN (6/21/2022, 7:04:00 PM)

After market: 63.74 +0.01 (+0.02%)

63.73

+0.37 (+0.58%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.06%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -35.42%
PM (TTM) -33.25%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y44.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)33.31%
Revenue growth 3Y35.02%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y